Anti-Human PODXL Polyclonal Antibody from ProteoGenix; catalogue ARO-A22000; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Anti-Human PODXL Polyclonal Antibody: A Powerful Tool for Targeting Cancer Cells
The Anti-Human PODXL Polyclonal Antibody is a highly specific and effective tool for researchers studying cancer and its progression. This antibody targets podocalyxin-like protein (PODXL), a glycoprotein that is overexpressed in many types of cancer cells. With its ability to bind to PODXL, this antibody can be used for a variety of applications in cancer research.
PODXL is a transmembrane protein that plays a crucial role in cell adhesion, migration, and invasion. In cancer cells, it is often upregulated and contributes to the aggressive behavior of tumors. By targeting PODXL, the Anti-Human PODXL Polyclonal Antibody can inhibit the functions of this protein, leading to decreased cancer cell migration and invasion.
This antibody has been widely used in cancer research for its ability to specifically target and inhibit PODXL. It can be used in immunohistochemistry, western blotting, and flow cytometry to detect and quantify PODXL expression in cancer cells. Additionally, this antibody can be used in functional studies to investigate the role of PODXL in cancer progression.
1. Detecting PODXL expression in cancer tissues: The Anti-Human PODXL Polyclonal Antibody can be used in immunohistochemistry to detect the expression of PODXL in cancer tissues. This can provide valuable information on the presence and distribution of PODXL in different types of cancer.
2. Inhibiting cancer cell migration and invasion: By targeting and binding to PODXL, this antibody can inhibit the functions of this protein, leading to decreased cancer cell migration and invasion. This can be studied using functional assays such as wound healing and invasion assays.
3. Investigating the role of PODXL in cancer progression: The Anti-Human PODXL Polyclonal Antibody can be used in knockdown or overexpression experiments to study the effects of PODXL on cancer cell behavior. This can provide insights into the mechanisms of cancer progression and identify potential therapeutic targets.
Conclusion:
The Anti-Human PODXL Polyclonal Antibody is a valuable tool for cancer research, offering a specific and effective way to target and study PODXL. With its multiple applications and experimental use cases, this antibody can provide valuable insights into the role of PODXL in cancer progression. Order now and take your cancer research to the next level.
ProteoGenix catalogue number ARO-A22000. For research use only.
Target: PODXL; Clonality: Polyclonal Antibody; Reactivity: Human; Applications: ELISA, WB, IHC.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Species | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| Human |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
